| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.91B | 3.86B | 3.30B | 3.30B | 2.46B | 12.35B |
| Gross Profit | 2.72B | 2.68B | 2.29B | 2.37B | 1.91B | 1.45B |
| EBITDA | 1.27B | 1.16B | 620.07M | 399.03M | 794.58M | 415.36M |
| Net Income | 735.17M | 668.38M | 339.89M | 198.66M | 438.71M | 218.90M |
Balance Sheet | ||||||
| Total Assets | 9.18B | 10.65B | 9.28B | 8.38B | 6.25B | 5.09B |
| Cash, Cash Equivalents and Short-Term Investments | 3.94B | 6.11B | 4.82B | 3.20B | 2.67B | 2.62B |
| Total Debt | 2.53B | 3.74B | 3.77B | 2.69B | 1.59B | 1.22B |
| Total Liabilities | 5.53B | 7.07B | 6.18B | 5.57B | 3.56B | 2.84B |
| Stockholders Equity | 3.65B | 3.58B | 3.10B | 2.81B | 2.69B | 2.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.57B | 619.55M | -383.06M | -91.81M | 463.27M |
| Operating Cash Flow | 0.00 | 1.58B | 626.07M | -298.55M | -84.57M | 484.71M |
| Investing Cash Flow | 0.00 | -87.55M | -27.26M | -178.20M | -55.94M | -31.89M |
| Financing Cash Flow | 0.00 | -196.52M | 915.25M | 1.02B | 282.12M | 363.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥30.06B | 13.16 | ― | 5.35% | 58.08% | 29.89% | |
69 Neutral | ¥15.31B | 14.99 | ― | 2.51% | 10.17% | 327.27% | |
68 Neutral | ¥13.55B | 21.11 | ― | 2.19% | 14.43% | 10.99% | |
66 Neutral | ¥20.16B | 7.57 | ― | 2.01% | 15.43% | 12.47% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | ¥13.86B | 19.09 | ― | 7.85% | -3.20% | 34.08% | |
50 Neutral | ¥13.01B | 16.25 | ― | ― | -2.68% | 91.68% |